MASSDEVICE ON CALL —Medtronic Inc.’s (NYSE:MDT) new CEO Omar Ishrak has big plan for the company, including a focused push toward India and a spotlight on mobile health care.
He called India the "biggest hole" in the company’s global reach, and the Minnesota-based med-tech goliath is looking for opportunities to build up its R&D efforts there.
Ishrak also highlighted the importance of capitalizing on a "highly mobile" health care environment, according to MedCity News, and defended the safety of its controversial Infuse bone graft protein, which is at the heart of allegations that Medtronic’s paid consultants may have concealed Infuse’s potential to increase infertility risk in men.
IBM’s Watson plays doctor
IBM’s Jeopardy-winning supercomputer Watson will help make diagnosis and treatment suggestions to physicians through health insurer WellPoint, the Wall Street Journal’s Health Blog reported.
Denver schools invest in defibrillators
Denver Public schools installed defibrillators at every facility starting last week, the Denver Post reported.
Implanted medical device infections treated with fungus killer
A fungus-targeting therapy may kill a potentially deadly type of infection common to catheters, artificial joints and other "in-dwelling" medical devices, according to a press release.
FDA pulls two "acne-treatment" apps off the market for false claims
The FDA fined two smartphone app-makers a total of more than $16,000 for making false claims that their apps could treat acne, MobiHealthNews reported.